Effectdossier · gearchiveerd kwartaal
ORGO
Organogenesis Holdings Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
15Gevolgde houders
-1Δ houders
28.00MGehouden aandelen
$118.17MGerapporteerde waarde
+0Nieuwe posities
−2Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders -6.2% ·
aandelenstroom -2.6% ·
netto nieuwe posities -13.3%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 65 | +3 | 49.96M | $121.38M | +7 | −3 |
| Q1 2026 | 63 | -8 | 40.42M | $96.13M | +5 | −14 |
| Q4 2025 | 72 | +2 | 50.45M | $261.28M | +3 | — |
| Q3 2025 | 15 | -1 | 28.00M | $118.17M | — | −2 |
| Q2 2025 | 14 | -1 | 16.35M | $59.84M | — | −1 |
| Q1 2025 | 12 | +1 | 8.11M | $35.03M | +1 | — |
| Q4 2024 | 11 | 0 | 8.24M | $26.36M | — | — |
| Q3 2024 | 10 | 0 | 7.43M | $21.26M | — | — |
| Q2 2024 | 10 | — | 6.90M | $19.31M | — | — |
Wie het bezit · Q3 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Morgan Stanley ✦ | 11.80M | — | $49.78M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Morgan Stanley ✦ | 11.80M | — | $49.78M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 11.80M | — | $49.78M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 11.80M | — | $49.78M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 11.80M | — | $49.78M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | The Vanguard Group ✦ (passief) | 5.04M | -3.1% | $21.25M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | The Vanguard Group ✦ (passief) | 5.04M | -3.1% | $21.25M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | The Vanguard Group ✦ (passief) | 5.04M | -3.1% | $21.25M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 4.58M | -3.1% | $19.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 4.58M | -3.1% | $19.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 4.58M | -3.1% | $19.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 4.58M | -3.1% | $19.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 4.58M | -3.1% | $19.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 4.58M | -3.1% | $19.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 4.58M | -3.1% | $19.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Geode Capital Management ✦ (passief) | 1.72M | +3.0% | $7.28M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passief) | 1.72M | +3.0% | $7.28M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | State Street Global Advisors ✦ (passief) | 1.52M | +0.8% | $6.42M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 821.50K | +2.2% | $3.47M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 706.77K | -1.4% | $2.98M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 706.77K | -1.4% | $2.98M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 706.77K | -1.4% | $2.98M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 706.77K | -1.4% | $2.98M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 511.64K | -16.5% | $2.16M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 511.64K | -16.5% | $2.16M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 428.66K | — | $1.81M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 428.66K | — | $1.81M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 428.66K | — | $1.81M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 428.66K | — | $1.81M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 428.66K | — | $1.81M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 428.66K | — | $1.81M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 428.66K | — | $1.81M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 428.66K | — | $1.81M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Fidelity (FMR) ✦ | 241.18K | +24.6% | $1.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 35 | Goldman Sachs Group ✦ | 229.29K | — | $967,587 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Goldman Sachs Group ✦ | 229.29K | — | $967,587 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Wellington Management ✦ | 229.14K | -45.4% | $966,975 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 38 | Wellington Management ✦ | 229.14K | -45.4% | $966,975 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 39 | Wellington Management ✦ | 229.14K | -45.4% | $966,975 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 40 | Millennium Management ✦ | 83.23K | -40.1% | $351,222 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 41 | Two Sigma Investments ✦ | 50.59K | -66.4% | $213,507 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 42 | T. Rowe Price ✦ | 36.45K | +10.8% | $154,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Citadel Advisors | $368,851 | was 0.0% |
| Norges Bank | $237,534 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 121 houders, 62.04M aandelen, $141.33M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q3 2025 ·
Methodologie ·
Verkrijg dit via de API